According to StockMKTNewz, President Trump announced he will sign an executive order to reduce prescription drug and pharmaceutical prices by 30% to 80% almost immediately (source: StockMKTNewz, May 11, 2025). This significant regulatory move could lead to sharp volatility in biotech and pharmaceutical stocks, as lower revenues may impact sector valuations. Crypto traders should monitor possible spillover effects, as rapid capital rotation out of healthcare equities could prompt increased inflows into digital assets and DeFi healthcare tokens, especially those offering pharmaceutical supply chain solutions.